A phase Ib/II trial of lenvatinib plus pembrolizumab in non-small cell lung cancer

Authors

Publication/Presentation Date

7-2019

Volume

37

Issue

8

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Share

COinS